Viral Protease Inhibitors
Showing 1 - 25 of 8,943
HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)
Recruiting
- HIV-1-infection
- Multi-Antiviral Resistance
- REGISTER CREATION
-
Milan, MI, ItalyOspedale San Raffaele
Dec 22, 2021
COVID-19 Trial in Minneapolis (Shionogi Protease Inhibitor (S-217622), )
Recruiting
- COVID-19
- Shionogi Protease Inhibitor (S-217622)
- placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 12, 2023
Protease Inhibitors in Chronic Hepatitis C
Completed
- Chronic Hepatitis C
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
Jan 11, 2023
HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease
Active, not recruiting
- HIV-1 Infection
- Doravirine, Tenofovir, Lamivudine
- +4 more
- (no location specified)
Sep 2, 2022
Metastatic Melanoma, Immune Checkpoints Inhibitors, Gastrointestinal Microbiome (Bacterial and Viral) Trial in Ljubljana (Immune
Recruiting
- Metastatic Melanoma
- +3 more
- Immune checkpoint inhibitor
-
Ljubljana, SloveniaInstitute of Oncology Ljubljana
May 17, 2023
HIV Trial in United States (Pravastatin sodium, Simvastatin, Atorvastatin calcium)
Completed
- HIV Infections
- Pravastatin sodium
- +5 more
-
Los Angeles, California
- +12 more
Oct 27, 2021
HIV Patients Trial in France (No intervention)
Completed
- HIV Patients
- No intervention
-
Créteil, France
- +5 more
Jul 30, 2021
HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)
Completed
- HIV Infections
- +2 more
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +8 more
Oct 28, 2021
HIV-1 Infection Trial in Badalona (Isentress® (Raltegravir, 400 mg every 12 hours), Isentress® (Raltegravir, 400 every 12
Completed
- HIV-1 Infection
- Isentress® (Raltegravir, 400 mg every 12 hours)
- Isentress® (Raltegravir, 400 every 12 hours)
-
Badalona, Barcelona, SpainGermans Trias i Pujol Hospital
Nov 11, 2019
HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)
HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose
Recruiting
- HIV I Infection
- Adiposity
- Frequently sampled glucose tolerance testing
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 15, 2022
Kidney Transplantation, Cytomegalovirus Infections Trial in L'Hospitalet de Llobregat (Switch from Mycophenolate Mofetil to
Not yet recruiting
- Kidney Transplantation
- Cytomegalovirus Infections
- Switch from Mycophenolate Mofetil to Everolimus manteinance treatment in Active Comparator Arm
- no intervention
-
L'Hospitalet de Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Jun 16, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +4 more
- Nirmatrelvir
- +2 more
-
Cooperstown, New York
- +10 more
Dec 11, 2022
HIV Trial in Canada, United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)
Completed
- HIV Infections
- Indinavir sulfate
- +2 more
-
San Francisco, California
- +43 more
Oct 27, 2021
HIV Trial in United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)
Completed
- HIV Infections
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +14 more
Oct 27, 2021